Os níveis séricos de Cyfra 21-1 são factores preditivos da sobrevida dos doentes com carcinoma pulmonar de não pequenas células submetidos a gefitinib como terapêutica de terceira linha.

Statistics

As Nossas Leituras\Our Readings

Cyfra 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy.

F. Barlési, C. Tchouhadjian, C. Doddoli, J.-P. Torre, P. Astoul, J.-P. Kleisbauer

Read

4388

Times
was read the article

2022

Total PDF

2366

Total HTML

Share statistics

Article information

ISSN: 08732159
Original language: Portuguese

DOI:10.1016/S0873-2159(15)30508-0

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 December	18	28	46
2024 November	33	37	70
2024 October	40	28	68
2024 September	28	25	53
2024 August	38	42	80
2024 July	25	45	70
2024 June	26	24	50
2024 May	28	29	57
2024 April	25	25	50
2024 March	24	22	46
2024 February	22	40	62
2024 January	21	31	52
2023 December	18	23	41
2023 November	13	21	34
2023 October	15	32	47
2023 September	15	30	45
2023 August	15	21	36
2023 July	22	18	40
2023 June	15	10	25
2023 May	21	19	40
2023 April	14	13	27
2023 March	24	28	52
2023 February	10	19	29
2023 January	14	16	30
2022 December	22	23	45
2022 November	21	27	48
2022 October	25	35	60
2022 September	13	29	42
2022 August	26	22	48
2022 July	15	37	52
2022 June	18	33	51
2022 May	25	34	59
2022 April	21	34	55
2022 March	22	31	53
2022 February	20	22	42
2022 January	16	34	50
2021 December	15	27	42
2021 November	16	22	38
2021 October	14	35	49
2021 September	16	25	41
2021 August	16	24	40
2021 July	14	20	34
2021 June	16	24	40
2021 May	27	30	57
2021 April	27	50	77
2021 March	34	16	50
2021 February	26	15	41
2021 January	24	18	42
2020 December	27	17	44
2020 November	27	17	44
2020 October	30	14	44
2020 September	29	18	47
2020 August	23	24	47
2020 July	38	17	55
2020 June	27	20	47
2020 May	34	21	55
2020 April	28	13	41
2020 March	28	11	39
2020 February	35	17	52
2020 January	34	12	46
2019 December	20	26	46
2019 November	39	14	53
2019 October	21	19	40
2019 September	28	14	42
2019 August	26	17	43
2019 July	16	11	27
2019 June	26	9	35
2019 May	28	17	45
2019 April	27	31	58
2019 March	42	14	56
2019 February	27	22	49
2019 January	26	21	47
2018 December	12	7	19
2018 November	10	1	11
2018 October	30	5	35
2018 September	9	6	15
2018 August	23	13	36
2018 July	34	11	45
2018 June	38	14	52
2018 May	40	17	57
2018 April	49	18	67
2018 March	38	12	50
2018 February	28	10	38
2018 January	25	15	40
2017 December	30	6	36
2017 November	32	19	51
2017 October	30	13	43
2017 September	26	10	36
2017 August	23	14	37
2017 July	11	3	14
2017 June	23	13	36
2017 May	27	6	33
2017 April	7	2	9
2017 March	15	18	33
2017 February	9	1	10
2017 January	10	4	14
2016 December	13	4	17
2016 November	7	6	13
2016 October	15	15	30
2016 September	3	1	4
2016 August	4	3	7
2016 July	3	7	10
2016 June	1	8	9
2016 May	7	0	7
2016 April	1	1	2
2016 March	9	8	17
2016 February	7	12	19
2016 January	4	2	6
2015 December	8	3	11
2015 November	2	1	3
2015 October	4	4	8

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter